Supernus and Indivior Complete Merger Creating a Diversified CNS Biopharmaceutical Leader
Supernus announced completion of its merger with Indivior Pharmaceuticals, launching Supernus, Inc. as a diversified biopharmaceutical company focused on central nervous system diseases.
Why it matters — The completed merger changes the company’s corporate structure and brings together Supernus and Indivior under Supernus, Inc.